Abstract:
In order to assess the social environment, disease status, and quality of life indicators of patients with cirrhosis
of the liver, an SF-36 survey proposed by the World Health Organization was used to determine the quality of life of 89
patients. The results obtained indicate a reliable difference in all scales of the SF-36 survey among individuals with liver
cirrhosis and healthy. Thus, the quality of life data contribute to the individualization of the treatment program, determine its
effectiveness and prognosis. To objectify the quality of life indicator, the testological approach has become widespread.
